Literature DB >> 29202484

Usefulness of the Martin Method for Estimation of Low-Density Lipoprotein Cholesterol in Coronary Atherosclerosis.

Soie Chung1.   

Abstract

OBJECTIVE: This study was conducted to validate the Martin method in coronary atherosclerosis in comparison with the Friedewald equation. SUBJECTS AND METHODS: A total of 299 participants with a coronary artery calcium score (CACS) ≥300 and a serum triglyceride (TG) level <400 mg/dL at Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea, were enrolled in this study. Low-density lipoprotein cholesterol (LDL-C) was directly measured with a homogeneous assay (DLDL) and estimated by both the Friedewald equation (FLDL) and Martin method (MLDL). Overall concordances between DLDL and LDL-C estimates were calculated as the percent agreement. The McNemar test was used to compare the rate of reclassification of participants with FLDL and MLDL, and to determine which differed significantly from each other.
RESULTS: Overall concordance between DLDL and MLDL was slightly higher than that between DLDL and FLDL (73.2 vs. 70.9%, p < 0.001). The FLDL showed poor performance when the TG level was ≥200 mg/dL, mostly by underestimation, which represented a 64.7% discordance with DLDL. The reclassification rate by MLDL, however, did not exceed 35.3% in all of the TG groups.
CONCLUSIONS: The Martin method to estimate LDL-C using the strata-specific TG:VLDL ratio showed a 2-fold better concordance with LDL-C measured with a direct homogeneous assay in coronary atherosclerosis compared to the Friedewald equation when the TG level was ≥200 mg/dL. This finding suggests that MLDL could be a better alternative for estimating LDL-C compared to FLDL when the TG level is ≥200 mg/dL in coronary atherosclerosis.
© 2017 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Coronary atherosclerosis; Friedewald equation; Low-density lipoprotein cholesterol

Mesh:

Substances:

Year:  2017        PMID: 29202484      PMCID: PMC5968229          DOI: 10.1159/000485977

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  23 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states.

Authors:  J S Cohn; J R McNamara; E J Schaefer
Journal:  Clin Chem       Date:  1988-12       Impact factor: 8.327

5.  Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures.

Authors:  W Greg Miller; Gary L Myers; Ikunosuke Sakurabayashi; Lorin M Bachmann; Samuel P Caudill; Andrzej Dziekonski; Selvin Edwards; Mary M Kimberly; William J Korzun; Elizabeth T Leary; Katsuyuki Nakajima; Masakazu Nakamura; Göran Nilsson; Robert D Shamburek; George W Vetrovec; G Russell Warnick; Alan T Remaley
Journal:  Clin Chem       Date:  2010-04-08       Impact factor: 8.327

6.  Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications.

Authors:  Seth S Martin; Michael J Blaha; Mohamed B Elshazly; Eliot A Brinton; Peter P Toth; John W McEvoy; Parag H Joshi; Krishnaji R Kulkarni; Patrick D Mize; Peter O Kwiterovich; Andrew P Defilippis; Roger S Blumenthal; Steven R Jones
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

7.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups.

Authors:  Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

8.  A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study.

Authors:  D M DeLong; E R DeLong; P D Wood; K Lippel; B M Rifkind
Journal:  JAMA       Date:  1986-11-07       Impact factor: 56.272

9.  Validity of a Novel Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Diabetic Patients.

Authors:  Hideto Chaen; Shigesumi Kinchiku; Masaaki Miyata; Shoko Kajiya; Hitoshi Uenomachi; Toshinori Yuasa; Kunitsugu Takasaki; Mitsuru Ohishi
Journal:  J Atheroscler Thromb       Date:  2016-09-02       Impact factor: 4.928

Review 10.  Cholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemia.

Authors:  Nabil A Elshourbagy; Harold V Meyers; Sherin S Abdel-Meguid
Journal:  Med Princ Pract       Date:  2013-12-11       Impact factor: 1.927

View more
  3 in total

1.  Martin Method for Estimation of Low-Density Lipoprotein Cholesterol.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Med Princ Pract       Date:  2018-08-14       Impact factor: 1.927

2.  Reply to the Comment Entitled "Martin Method for Estimation of Low-Density Lipoprotein Cholesterol".

Authors:  Soie Chung
Journal:  Med Princ Pract       Date:  2018-09-10       Impact factor: 1.927

3.  Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.

Authors:  Gözde Ertürk Zararsız; Serkan Bolat; Ahu Cephe; Necla Kochan; Serra İlayda Yerlitaş; Halef Okan Doğan; Gökmen Zararsız
Journal:  PLoS One       Date:  2022-05-13       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.